Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Mongodb Inc (MDB) Price & Performance

Axogen IncTrade
Mongodb IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Mongodb Inc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Mongodb Inc trades at $345.96 (market cap $27.72B). The key difference: Mongodb Inc is far larger — about 13.5× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Mongodb Inc nearer its low. Which is the better fit depends on your goals.

AXGNMDB
Market Cap
$2.06B$27.72B
Sector
TechnologyTechnology
52-Week High
$46.19$440.25
52-Week Low
$11.28$201.08
Enterprise Value
$1.98B$25.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

Mongodb Inc

MongoDB (MDB) trades at $337.59, down 1.31% on the day, with a bullish technical signal from moving averages and oversold short-term RSI. Revenue growth remains strong, reaching $2.01 billion in 2025, though the company is not yet profitable, posting a net loss of $129 million. Recent news highlights AI-driven demand boosting database sales, with the company raising FY2027 revenue guidance to $2.92–$2.96 billion, signaling robust growth prospects.

The outlook is positive given strong analyst support (81.8% buy ratings) and a $400.39 consensus price target, implying 18.6% upside. Key risks include ongoing losses, competitive pressures, and potential legal scrutiny from shareholder investigations. Earnings beats in recent quarters and projected narrowing losses by 2026 support a growth-oriented investment case, but profitability remains a critical watchpoint.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Mongodb Inc

Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.

Read more on MDB